Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

OBJECTIVES: This post hoc analysis of data from a randomized, double-blind, placebo-controlled, enriched-enrollment randomized-withdrawal Phase III study evaluated the safety, tolerability, and analgesic efficacy of Oxycodone DETERx extended-release (ER), abuse-deterrent capsules (Xtampza(®) ER) in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pain Res
Autors principals: Markman, John, Meske, Diana S, Kopecky, Ernest A, Vaughn, Ben, O’Connor, Melinda L, Passik, Steven D
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6163025/
https://ncbi.nlm.nih.gov/pubmed/30288095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S168836
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars